Table 1 Histologic and phase characteristics of sensitive and resistant NSGCTs
From: Role of promoter hypermethylation in Cisplatin treatment response of male germ cell tumors
| Â | Sensitive (N = 31) | Resistant (N = 39) |
|---|---|---|
Histology | Â | Â |
   Teratoma | 14 | 15 |
   Embryonal carcinoma | 6 | 2 |
   Yolk sac tumor | 3 | 6 |
   Mixed tumor/malignant transformation | 8 | 16 |
Phase at tissue collection | Â | Â |
   Primary untreated (P) | 1 | 5 |
   Metastatic untreated (M1) | 12 | 4 |
   One regimen of chemotherapy (C1) | 18 | 14 |
   Two regimens of chemotherapy (C2) | - | 8 |
   Three or more regimens of chemotherapy (C3) | - | 8 |